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 TSG-6  that encodes a protein involved in cell adhesiveness. 
Of these, expression of  mGluR1 also increases in the female 
monkey hypothalamus at puberty.  Conclusions: Increased 
expression of these genes in HHs may be relevant to the abil-
ity of some HHs to induce sexual precocity. 
 Copyright © 2007 S. Karger AG, Basel 
 Introduction 
 Puberty results from the activation of a complex neu-
roendocrine machinery set in motion by a primary mech-
anism yet to be identified. Once under way, this activa-
tional process results in the diurnally timed resurgence 
of pulsatile gonadotropin hormone-releasing hormone 
(GnRH) secretion, which in turn stimulates the secretion 
of luteinizing hormone and follicle-stimulating hormone 
from the pituitary gland.
 It appears now well-established that GnRH secretion 
during sexual development is mainly controlled by neu-
ronal networks utilizing excitatory and inhibitory amino 
acids for neurotransmission. It is also believed that the 
pubertal activation of GnRH release depends on a coor-
dinated increase in glutamatergic stimulation of GnRH 
neurons and a decrease in   -aminobutyric acid inhibi-
tion [reviewed in  1 ]. In addition to these ‘classical’ neu-
rotransmitters, the peptide metastatin/kisspeptin pro-
duced by discrete hypothalamic neuronal subsets  [2] has 
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 Abstract 
 Background: Hypothalamic hamartomas (HHs) are congen-
ital lesions composed of neurons and astroglia. Frequently, 
HHs cause central precocious puberty (CPP) and/or gelastic 
seizures. Because HHs might express genes similar to those 
required for the initiation of normal puberty, we used cDNA 
arrays to compare the gene expression profile of an HH as-
sociated with CPP with three HHs not accompanied by sex-
ual precocity.  Methods: Global changes in gene expression 
were detected using Affymetrix arrays. The results were con-
firmed by semiquantitative PCR, which also served to exam-
ine the expression of selected genes in the hypothalamus of 
female monkeys undergoing puberty.  Results: All HHs were 
associated with seizures. Ten genes whose expression was 
increased in the HH with CPP were identified. They encode 
proteins involved in three key cellular processes: transcrip-
tional regulation, cell-cell signaling, and cell adhesiveness. 
They include  IA-1 and  MEF2A , two transcription factors re-
quired for neuronal development;  mGluR1 and VILIP-1 , which 
encode proteins involved in neuronal communication, and 
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been recently identified as playing a pivotal role in the 
initiation of puberty  [3, 4] . GnRH neuronal activity is not 
only controlled by these transsynaptic inputs, but also by 
glial cells that facilitate GnRH secretion via the activation 
of signaling pathways initiated by growth factors acting 
on receptors endowed with tyrosine- and serine-threo-
nine kinase activity [reviewed in  1 ].
 The search for those precipitating events responsible 
for the initiation of puberty may benefit not only from 
studying the normal process of puberty in animal models 
and humans, but also from the analysis of pathological 
conditions affecting pubertal development in humans. 
Hypothalamic hamartomas (HHs) represent one of these 
conditions. They are congenital nonneoplastic lesions 
containing mature brain tissue in a heterotopic location, 
commonly associated with the base of the hypothalamus 
 [5] . In most cases, HHs contain neurons and astroglial 
cells of normal aspect in addition to astrocytes and epen-
dymoglial-like cells  [6] . If HH are symptomatic, they are 
frequently associated with central precocious puberty 
(CPP) and/or gelastic seizures, a form of ictal laughter 
 [7] .
 In both sexes, sexual precocity caused by HH occurs 
much earlier (1–2 years of age) than idiopathic precocious 
puberty, which predominantly affects females. The mech-
anism by which they advance puberty so dramatically is 
still unknown. Because HHs appear to contain all the 
necessary components to initiate the pubertal process at 
a very early age, they might hold critical information con-
cerning the transcriptional and/or signaling components 
underlying sexual precocity and the initiation of normal 
puberty in humans. In this study, we used cDNA micro-
arrays to compare the gene expression profiles of an HH 
associated with CPP to that of HHs not accompanied by 
precocious puberty with the aim of identifying genes 
whose expression may be selectively altered in the HH 
with CPP. The results showed the genes most highly over-
expressed in the HH associated with CPP were genes en-
coding transcriptional regulators required for neuronal 
differentiation and survival, and genes encoding proteins 
required for excitatory cell-cell communication.
 Patients and Methods 
 Patients 
 HHs from 4 patients were used for DNA array analysis and 
semiquantitative PCR. In addition, the expression of selected 
genes from a fifth HH was analyzed by semiquantitative PCR 
only. In all cases, the HHs were surgically resected due to intrac-
table seizure activity. With the exception of patient 3 and 5, all 
other patients were males. Only patients 1 and 5 exhibited CPP 
before surgery ( table 1 ). However, the evolution of these two cases 
was different, because the HH of patient 5 was removed at 14 years 
of age (9 years after CPP was diagnosed), during the course of 
normal puberty and 1 year after discontinuation of treatment 
with a GnRH agonist. The HH of patient 1 was resected much 
sooner (at approximately 8 years of age), 4 years after the mani-
festation of CPP, and while the patient was still being treated with 
a GnRH agonist. The 3 other patients had seizures, but not CPP 
at the time of HH resection. Patient 3 (female) exhibited CPP 3 
months  after surgery ( table 1 ). A fragment of each HH was rou-
tinely processed for histopathological examination, and tissue 
samples not needed for diagnostic purposes were stored at –80  °  C 
for future reference or research.
 These preexisting samples were sent to Beaverton, Oreg., USA 
as unlinked, anonymous specimens for RNA processing. The ex-
perimental protocol for this project was approved by the Institu-
tional Review Board for Human Subjects of the Oregon Health & 
Science University.
 Nonhuman Primates 
 The hypothalamic tissue used in this study derived from early 
juvenile (8.9–11.7 months of age, n = 5), late juvenile (1.2–1.8 years 
of age, n = 4), early pubertal (2–3 years of age, n = 4) and mid-pu-
bertal (3–4 years of age, n = 6) female monkeys  (Macaca mulatta) 
that had been euthanized for a variety of reasons and obtained 
through the Oregon National Primate Research Center (ONPRC) 
Necropsy Program. The developmental stages of the animals were 
defined according to the criteria proposed by Watanabe and
Table 1. HHs used in this study and associated clinical characteristics





1 7 years, 8 months Yes M 3–4 years Yes Yes
2 9 years No M – – Yes
3 5 years, 2 months 3 months after surgery F 5 years, 3 months Yes
4 37 years No M – – Yes
5 14 years Yes F 5 years Yes1 Yes
1 Discontinued before surgery.
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Terasawa  [8] . All procedures were approved by the ONPRC Ani-
mal Care and Use Committee in accordance with the NIH guide-
lines for the use of animals in research.
 RNA Extraction 
 Total RNA from the HH samples and the nonhuman primate 
brain was extracted as outlined in online supplementary note 1 
(www.karger.com/doi/10.1159/000111815). RNA from the human 
placenta and human fetal brain was purchased from BD Biosci-
ences (San Jose, Calif., USA); total RNA from human hypothala-
mi was obtained from Ambion (Austin, Tex., USA).
 Sample Preparation and Microarray Hybridization 
 Microarray assays were performed by the Affymetrix Micro-
array Core of the OHSU Gene Microarray Shared Resource, as 
described in online supplementary note 2 (www.karger.com/
doi/10.1159/000111815).
 Microarray Data Analysis 
 Image processing and expression analysis were carried out us-
ing Affymetrix Microarray Suite (MAS) 5.0 software, as described 
in online supplementary note 3 (www.karger.com/doi/10.1159/
 000111815) . The array data have been deposited in NCBIs Gene 
Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/; 
accession number GSE7142).
 Semiquantitative PCR Validation of Array Results 
 Five genes showing an increased expression of 2-fold or great-
er in the HH associated with CPP (patient 1, male) versus the HHs 
from the 2 male patients without CPP (patients 2 and 4), and the 
HH from a female patient showing puberty after surgery (HH-3) 
were selected for PCR verification of the array results. The same 
genes were also examined in an additional HH (patient 5) not 
subjected to array analysis. The five genes studied were  IA-1,
VILIP-1, TSG-6, mGluR1A, and  MEF2A ( table 2 ). Reverse tran-
scription of total RNA (50 ng) from each sample and PCR ampli-
fication was performed as outlined in online supplementary note 
4 (www.karger.com/doi/10.1159/000111815). Other genes exam-
ined were  GnRH, TGF  , KiSS1, and  GPR54 using primers and 
PCR conditions described in online supplementary note 4. Den-
sitometric analysis of the gels was performed using Quantity One 
software (Bio-Rad, Hercules, Calif., USA). The results are ex-
pressed as arbitrary units resulting from dividing the densitomet-
ric value obtained for each mRNA of interest by the correspond-
ing cyclophilin value found in each sample.
 Semiquantitative PCR Analysis of IA-1, TSG-6 and mGluR1A 
mRNA Expression in Monkey Hypothalamus 
 Five hundred nanograms of total RNA from each sample were 
reverse transcribed as indicated above. The PCR primers (online 
suppl. note 5, www.karger.com/doi/10.1159/000111815), chosen 
using Primer Express software (PR Applied Biosystems) were se-
lected from monkey cDNA sequences (http://www.hgsc.bcm.
tmc.edu/projects/rmacaque).
 Statistics 
 Differences between two groups were analyzed using the Stu-
dent t test. When comparing several groups, the differences were 
analyzed by one-way ANOVA followed by the Student-Newman-
Keuls multiple comparison test for unequal replications.
 Results 
 Identification of Genes Predominantly Expressed in 
an HH Associated with CPP 
 To identify genes sharing a similar expression profile 
in HH-1 (the HH from patient 1 who had CPP and sei-
zures) in comparison to HH-2 to 4 (the HHs from pa-
tients 2–4 who had seizures, but not CPP at the time of 
surgery), we used a K-means clustering algorithm pro-
vided by J-Express 2.0 software (http://www.ii.uib.no/
  bjarted/jexpress). A group of 10 genes whose expres-
Table 2. Genes showing a 2-fold increase or more in an HH associated with precocious puberty (HH-1) in comparison to HHs not ac-
companied by sexual precocity (HH-2 to 4)
Accession
No.
Gene identity 1- vs. 2-fold 
increase
1- vs. 3-fold 
increase




U30872.1 Centromere protein F (mitosin) 4.29 3.25 6.5 4.68
NM_002196.1 Insulinoma-associated 1 (IA1) 4.29 2.3 10.56 5.72
NM_005587.1 MEF2A transcription enhancer factor 2 3.48 2 2.83 2.77
NM_000838.2 Glutamate receptor metabotropic 1  (mGluR1A) 3.48 2.14 3.73 3.13
NM_003385.1 Visinin-like 1 (VILIP-1) 3.73 2.3 4.59 3.54
AI040163 Calcium channel, voltage-dependent, 2-subunit 3.73 2 3.03 2.92
AF047033.1 Solute carrier family 4, sodium bicarbonate cotransporter,
member 7 (SLC4A7) 2.64 2.14 2.64 2.47
AJ300461.1 Transmembrane protein 16C (C11ORF25) 5.28 4 6.5 5.26
R41498 T cell activation leucine repeat-rich protein 3.25 2.83 3.25 3.11
NM_007115 Tumor necrosis factor alpha-stimulated gene 6 (TSG-6) 3.73 2.3 3.73 3.25
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sion was consistently greater (2-fold or more) in HH-1 
than in HH-2 to 4 was selected ( table 2 ). The functions of 
the encoded proteins were determined using three differ-
ent search tools: the Swiss-Prot database (www.expasy.
ch), GOMiner (http://discover.nci.nih.gov/gominer/) 
and IHOP (www.ihop-net.org/UniPub/iHOP/). This 
analysis indicated that the genes overexpressed in HH-1 
encode proteins involved in three fundamental cellular 
processes: transcriptional regulation, cell-cell communi-
cation and cell adhesiveness ( table 3 ). With the possible 
exception of  CENP-F (mitosin), a cell cycle-regulated nu-
clear protein  [9] found at very low levels in the normal 
brain (http://source.stanford.edu), but that is overex-
pressed in malignant tissues, including astrocytomas and 
meningiomas [ 10 and references therein], all other genes 
are highly expressed in the normal developing brain in 
either neurons, astrocytes or both ( table 3 ).
 Validation of the Array Results by
Semiquantitative PCR 
 Based on their perceived importance in the control of 
HH cell function, five of the genes overexpressed in HH-
1 were selected for PCR validation:  IA-1  and MEF2A , two 
transcriptional regulators  [11, 12] ;  mGluR1 and  VILIP-1, 
two genes encoding proteins involved in cell-cell signal-
ling  [13, 14] , and  TSG-6 , a gene encoding a multifunc-
tional secreted protein that participates in cell-cell adhe-
sion via binding to hyaluronan, a component of the ex-
tracellular matrix  [15] .
 The increased abundance of  IA-1 mRNA detected by 
PCR in HH-1 as compared to HH-2 and 4 (all from male 
patients) was essentially identical to that detected by 
DNA arrays ( fig. 1 a). HH-3, derived from a female patient 
who developed CPP shortly after HH resection, exhibited 
an abundance of  IA-1 mRNA intermediate between HH-
Table 3. Cellular and molecular functions of genes showing a 2-fold increase or more in an HH associated with precocious puberty 
(HH-1) in comparison to HHs not accompanied by sexual precocity (HH-2 to 4)
Gene identity Cellular process Molecular function Tissue specificity TRG





Insulinoma-associated 1 (IA1) Transcriptional
regulation






MEF2A transcription enhancer factor 2 Transcriptional
regulation
Activates transcription Muscle, 
brain
Yes







Visinin-like 1 (VILIP-1) Cell-cell
communication
Calcium sensor protein Brain, pancreas Yes 






Brain, heart, pancreas No
Solute carrier family 4, sodium bicarbonate 
cotransporter, member 7 (SLC4A7)
Cell-cell
communication
Coupled transport of sodium 
and bicarbonate: maintains 
intracellular pH 
Brain, testis, spleen No
Transmembrane protein 16C (C11ORF25) Cell-cell
communication
Transporter for unidentified 
substrate
Ear, brain Yes
T cell activation leucine repeat-rich protein Cell-cell 
communication
Membrane protein Brain (adult and fetal), 
kidney, ovary 
No





Hyaluronic acid binding 
protein 
Brain, ovary Yes
TRG = Tumor-related gene.
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1, HH-2 and HH-4, suggesting that  IA-1 expression might 
have been already increasing at the time of surgery.  IA-1 
mRNA levels were not elevated in HH-5, which was re-
moved from a female patient 9 years after the diagnosis 
of CPP was made.
 Consistent with the array results,  MEF2A mRNA con-
tent measured by PCR was higher in HH-1 than in HH-2 
and 4 ( fig. 1 b). However,  MEF2A mRNA levels in HH-1 
were similar to those in HH-3, a finding at variance with 
the array results that detected a 2-fold increase in  MEF2A 
expression in HH-1 as compared to HH-3 ( table 2 ). Like 
 IA-1 mRNA,  MEF2A expression was as low in HH-5 as in 
HH-2 and 4.
 The differences in  mGluR1A and  VILIP-1 mRNA 
abundance between HH-1 versus HH-2, 3 and 4, assessed 
by semiquantitative PCR, were similar to those estimated 
by the arrays ( fig. 2 a, b). HH-5 had  VILIP-1 mRNA levels 
as high as in HH-1, but  mGluR1A mRNA values as low as 
in HH-2, 3 and 4, suggesting that not all genes with in-
creased expression in HHs associated with CPP remain 
permanently activated. As in the case of  IA-1 and 
 mGluR1A , there was excellent agreement between the 
 TSG-6  mRNA levels detected by PCR and the arrays 
( fig. 2 c).  TSG-6 mRNA prevalence in HH-5 was as low as 
in HH-2, 3 and 4.
 Expression of GnRH, TGF  , KiSS1 and GPR54
in HHs 
 Because earlier reports showed the presence of GnRH 
[ 16 and references therein] and  TGF   [17] in HHs, ex-
pression of these genes was also examined. In addition, 
we sought to determine if  KiSS1 and  GPR54 are expressed 
in HHs, because of recent findings indicating that activa-
tion of GPR54 receptors by kisspeptin, the processed pro-
tein product of the  KiSS1 gene, is a critical transsynaptic 
input to GnRH neurons required for the initiation of pu-
berty  [3, 4] .
 As shown in  figure 3 a and b, both  GnRH and  TGF  
mRNAs were detected in all five HHs examined, regard-
less of their association with CPP.  GnRH mRNA levels 
were higher in HH-2, despite the lack of association of 
this HH with precocious puberty, and TGF  mRNA 
abundance was highest in HH-3, which resulted in CPP 
after resection of the tumor.  KiSS1 mRNA was undetect-
able in all five HHs ( fig. 3 c), but  GPR54 mRNA was ex-
pressed in some HHs (HH-1 to 3), and absent in others 
(HH-4 and 5) ( fig. 3 d). Thus activation of GPR54 recep-
tors within HHs does not appear to be a primary mecha-
nism by which HHs induce sexual precocity.
 Ontogeny of IA-1, mGluR1A and TSG-6 Expression in 
the Female Monkey Hypothalamus 
 Because  IA-1, mGluR1A and  TSG-6 expression is con-
sistently increased in HH-1, we sought to determine if 
similar changes occur in the primate hypothalamus dur-
ing the normal onset of puberty. Female rhesus monkeys 
were used, because the intrinsic neuroendocrine mecha-
 Fig. 1. Selective overexpression of the mRNAs encoding the tran-
scriptional regulators IA-1 ( a ) and MEF2A ( b ) in an HH associ-
ated with CPP (HH-1) as compared with three HHs not accom-
panied by CPP (HH-2 to 4), and one HH (HH-5) removed 9 years 
after the occurrence of CPP. White bars represent the relative lev-
els of  IA-1 and  MEF2A mRNAs detected by cDNA arrays, using 
the mRNA levels found in HH-1 as 100%. Black bars represent 
relative expression levels detected by semiquantitative PCR, nor-
malized to the cyclophilin mRNA content of each sample, and 
calculated using the mRNA levels in HH-1 as 100%. The gels de-
picting the PCR products used to calculate these densitometric 
values are shown on top of each bar graph. – = PCR, no RT con-
trol. 
 Gene Expression Profiling of 
Hypothalamic Hamartomas 
Horm Res 2008;69:114–123 119
nisms underlying the onset of puberty in this species are 
similar to those operating in humans  [18] . The content of 
 mGluR1A mRNA increased (p  ! 0.05) in the hypothala-
mus ( fig. 4 a), but not in the cerebral cortex (inset), at the 
initiation of puberty, remaining moderately elevated 
thereafter. Neither  IA-1 nor  TSG-6 mRNA abundance in-
creased in the hypothalamus during postnatal develop-
ment ( fig. 4 b, c).
 Identification of Genes with Decreased Expression in 
HH with CPP 
 Fifteen genes showed a 2-fold or greater decrease in 
expression in HH-1 as compared with HH-2 to 4 (online 
 Fig. 2. Selective overexpression of the mRNAs encoding the cell-
cell communication molecules mGluR1A ( a ), VILIP-1 ( b ) and 
TSG-6 ( c ) in an HH associated with CPP (HH-1) as compared 
with three HHs not accompanied by CPP (HH-2 to 4), and one 
HH (HH-5) removed 9 years after the occurrence of CPP. White 
bars represent the relative levels of  mGLuR1A, VILIP-1 and  TSG-
6 mRNAs detected by cDNA arrays, using the mRNA levels found 
in HH-1 as 100%. Black bars represent relative expression levels 
detected by semiquantitative PCR, normalized to the cyclophilin 
mRNA content of each sample, and calculated using the mRNA 
levels in HH-1 as 100%. The gels depicting the PCR products used 
to calculate these densitometric values are shown on top of each 
bar graph. – = PCR, no RT control. 
 Fig. 3. The genes encoding GnRH ( a ), TGF  ( b ), KiSS1 ( c ) and 
GPR54 ( d ) are not selectively expressed in an HH associated with 
CPP (HH-1) in comparison to three HHs not accompanied by CPP 
(HH-2 to 4), and one HH (HH-5) removed 9 years after the occur-
rence of CPP. Notice that while  GnRH and  TGF  are expressed in 
all HHs,  KiSS1 is not expressed in any. In contrast  GPR54 mRNA 
is found in three of the five HHs studied. Also notice that  TGF  
mRNA abundance is higher in HH-3, which was resected from a 
patient who underwent CPP not before, but shortly after surgery. 
MM = Molecular marker; – = PCR, no RT control; HH = human 
hypothalamus; HFB = human fetal brain; HP = human placenta. 
 Parent  /Matagne  /Westphal  /Heger  /
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suppl. table 1, www.karger.com/doi/10.1159/000111815). 
The greatest decrease observed was in glutathione S-
transferase M5  (GSTM5) mRNA levels. GSTM5 is an 
enzyme that contributes to the detoxification of carcin-
ogens, products of oxidative stress, and environmental 
toxins, by conjugation with glutathione  [19] . Like the 
other 14 genes with decreased expression in HH-1, the 
contribution of  GSTM5 to HH-induced puberty is ob-
scure.
 Discussion 
 The present study demonstrates that expression of a 
discrete cohort of genes involved in transcriptional con-
trol, cell-cell communication and cell adhesiveness is in-
creased in an HH associated with sexual precocity in 
comparison with HHs that do not elicit advanced sexual 
development. The common feature linking all cases (in-
cluding HH-5, which was not analyzed by DNA arrays) 
is that all patients had seizures, and all had been unsuc-
cessfully treated with antiepileptic drugs prior to surgery. 
However, because HHs are only resected when they give 
rise to intractable seizures, the number of HHs available 
for analysis was necessarily small and variable with re-
gard to age at surgery, gender of the patients, and puber-
tal history.
 Despite these differences, the selective increase in gene 
expression observed in HH-1 was remarkably consistent 
with the neuroendocrine clinical features of each patient. 
Thus HH-2 and 4, derived from patients in whom sexual 
precocity never occurred, exhibited essentially identical 
differences in gene expression when compared to HH-1. 
The differences between HH-1 and HH-3 were uniform-
ly less accentuated, and they were more variable in the 
case of the few HH-5 genes examined. It is, therefore, pos-
sible that the initiation of puberty observed in patient 3 
after surgery may have been related to activation of the 
same genes whose expression is increased in HH-1. The 
increased prevalence of TGF  mRNA found in this HH 
is consistent with this possibility. Judging from the lim-
ited information gathered from HH-5, it would also ap-
pear that gene activation is not a permanent feature of 
HH neuropathology. The fact that sexual precocity was 
arrested in patients 1 and 5 by long-term GnRH antago-
nist treatment is also an important factor that needs to be 
taken into account when interpreting the results, because 
the GnRH treatment itself may have caused some of the 
changes in gene expression we detected.
 The present results do not identify gene defects that 
may be responsible for the development of HHs, but sug-
gest that HHs associated with CPP have a gene expression 
profile distinct from that of HHs not eliciting premature 
sexual development. They also suggest that genes show-
ing increased expression in the HH associated with CPP 
may be more useful for an understanding of this condi-
 Fig. 4. Expression of  mGluR1A  ( a ), but not that of  IA-1 ( b ) or  TSG-
6 ( c ), increases in the medial basal hypothalamus (MBH) of fe-
male rhesus monkeys at the time of puberty, as assessed by semi-
quantitative PCR. Values are expressed as the ratio between each 
gene of interest and the levels of cyclophilin mRNA detected in 
each sample. The increase in hypothalamic mGluR1A mRNA 
content was not observed in the cerebral cortex (CTX,  inset in  a ). 
 * p  ! 0.05 vs. early juvenile group. EJ = Early juvenile (8.9–
11.7 months of age); LJ = late juvenile (1.2–1.8 years of age); EP = 
early puberty (2–3 years of age); MP = mid-puberty (3–4 years 
of age). Bars are mean and vertical bars represent SEM. Num-
bers on top of bars in  a indicate the number of animals per 
group.  
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tion than genes with a decreased expression. Examina-
tion of additional HHs associated with sexual precocity 
is necessary to verify the validity of these concepts.
 We recently used DNA microarrays to query the hy-
pothalamus of female rhesus monkeys during pubertal 
development (Roth et al., unpubl. data), and quantitative 
proteomics to identify hypothalamic proteins that might 
be down- or upregulated in a mouse model of delayed 
puberty  [20] . The results of these studies showed that ex-
pression of certain genes previously described as being 
involved in ‘tumor suppression’ – but that otherwise play 
a role in maintaining normal cell differentiation process-
es – increases in the hypothalamus at the time of monkey 
puberty (Roth et al., unpubl. data) or decreases in mice 
with delayed puberty  [20] . A prominent example of a tu-
mor suppressor gene now found to play a critical role in 
the initiation of puberty is  KiSS1  [3, 4] . Before its function 
in the control of puberty was discovered, KiSS1 was 
known as a suppressor of tumor metastases  [21] .
 Of the 10 genes showing increased expression in HH-
1, six had been earlier proposed to have roles in tumor 
suppression. One of them is  CENP-F  [10] . Two others,  IA-
1 (insulinoma-associated-1, also known as  INSM1 ) and 
 MEF2A , are transcription factors. IA-1 is a zinc finger 
transcriptional repressor involved in neuronal differen-
tiation with expression restricted to the embryonic ner-
vous system and neuroendocrine tumors [ 11 and refer-
ences therein]. MEF2A, is a transcription factor also re-
quired for neuronal differentiation and survival  [12] , in 
addition to dendritic arborization and dendritic spine 
formation  [22] . Two additional genes related to tumor 
formation play a physiological role in cell-cell communi-
cation. One of them,  VILIP-1 (visinin-like protein-1) is a 
member of the family of neuronal calcium sensor pro-
teins  [14] ; loss of  VILIP-1 expression is associated with 
accelerated tumor cell invasiveness  [23] .  C11ORF25 en-
codes an eight-transmembrane protein with similarity to 
three other genes located on chromosomes 11 and 12; like 
other members of the family,  C11ORF25 is amplified in 
malignant tumors  [24] . C11ORF25 is predicted to be in-
volved in the intracellular transport of yet to be identified 
molecules. Finally,  TSG-6 (tumor necrosis factor-stimu-
lated gene 6) was also highly expressed in HH-1. TSG-6 
is a multifunctional protein secreted in response to TNF  
stimulation and elevated cAMP levels that binds to hyal-
uronan, a component of the extracellular matrix  [15] . As 
a downstream component of p53-mediated cell cycle ar-
rest  [25] ,  TSG-6 is a potential tumor suppressor gene. It 
thus appears that in both normal puberty and HHs there 
is an activation of genes that, having diverse cellular func-
tions, share the common feature of having been earlier 
identified as involved in tumor suppression.
 An additional gene encoding a protein involved in 
cell-cell communication and found to be upregulated in 
HH-1 is much less well-characterized. This gene, T cell 
activation leucine-rich repeat containing 8  (LRRC8) is a 
member of a highly conserved family of leucine-rich re-
peat proteins; LRRC8 may function as a receptor for an 
unknown ligand  [26] .
 Two genes encoding proteins involved in transmem-
brane ion mobilization are also overexpressed in HH-1: a 
splice variant of the L-type high voltage-activated Ca v 1.2 
channel   -subunit  [27] , and the sodium bicarbonate co-
transporter  NBC3 (SLC4A7)  [28] . The   -subunits of L-
Ca 2+  channels are critical modulators of the channel’s 
gating activity, and are required for the correct targeting 
of the Ca v 1.2 complex to the cell membrane  [29] . Sodium-
coupled bicarbonate transporters are essential for the ho-
meostatic maintenance of intracellular pH  [28] . Mice 
lacking  NBC3 develop blindness and hearing loss due to 
degeneration of the corresponding sensory receptors, a 
condition similar to Usher syndrome  [30] .
 Among the genes showing increased expression in 
HH-1,  IA-1 and  VILIP-1 deserve special mention because 
of their reported role in pancreatic   -cell/intestinal en-
docrine cell differentiation  [31] and insulin secretion 
 [32], respectively. Like in the pancreas,  IA-1 might func-
tion in HHs to promote the differentiation of neurosecre-
tory cells.  IA-1 is highly expressed in the fetal brain, pan-
creas, and neuroendocrine tumors, but is absent in adult 
tissues  [11, 33] .  VILIP-1 , a neuronal calcium sensor pro-
tein  [14] , is also expressed in pancreatic   -cells where it 
modulates insulin secretion instead of cell differentiation 
 [32] .  VILIP-1 also appears to mediate metabotropic re-
ceptor-induced synaptic plasticity  [34] . Conceivably, 
coupling of mGluR1 to VILIP-1 may set in motion cAMP-
and cGMP-dependent pathways  [14] that enhance the se-
cretion of substances, such as PGE 2 , able to stimulate 
GnRH release. These considerations suggest that the de-
fining feature distinguishing HHs able to induce CPP 
from HHs not associated with sexual precocity is the 
presence of active neuroendocrine cells in HHs causing 
CPP. Of interest in this context is a recently described 
case of precocious puberty in a 2-year-old girl caused by 
a pancreatic neuroectodermal tumor  [35] .
 Previous studies showed that HHs are composed of 
mature neuronal and glial elements  [36, 37] . The func-
tions of the 10 genes found to be overexpressed in HH-1 
provide molecular support to this concept, because all of 
them, with the possible exception of  CENP-F , are involved 
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in the regulation of differentiated neural cell functions 
 [12, 13, 22, 27, 28, 38] . Noteworthy, the overexpression of 
 TSG-6 , a gene encoding a secreted protein that binds to 
the extracellular matrix component glycosaminoglycan 
hyaluronan  [15], may reflect the presence of growth fac-
tor-producing glia in HH-1, because TSG-6 synthesis is 
strongly upregulated by glial growth factors, such as 
bFGF, TGF  , TNF  and TGF   [39] .
 Also of interest is the finding that all five HHs con-
tained  GnRH and  TGF  mRNA, but only HH-1 and HH-
5 were associated with precocious puberty before surgery, 
suggesting that GnRH neurons and TGF  -producing 
glia in HHs require a set of additional genes to become 
engaged in the cascade of events that allow HHs to induce 
sexual precocity. Interestingly, HH-3 had not only the 
gene expression profile most similar to HH-1, but also 
exhibited elevated TGF  mRNA levels, suggesting that 
this combination may have contributed to the prompt, 
and surprising, initiation of puberty seen in this patient 
after removal of the HH. The additional genes required 
for HHs to induce precocious puberty do not appear to 
include the KiSS1/GPR54 signaling complex because 
none of the HHs expressed KiSS1 mRNA, and the pres-
ence of GPR54 receptors was unrelated to the ability of 
the HH to elicit sexual precocity.
 The onset of normal female puberty in nonhuman pri-
mates was not accompanied by increased hypothalamic 
expression of  IA-1 or  TSG-6 , but it did show an increased 
abundance of  mGluR1A  mRNA. These findings suggest 
that either the increases in  IA-1 and  TSG-6 mRNA con-
tent observed in HH-1 do not occur during normal pu-
berty, or that they reflect the presence in the HH of a 
subset of differentiated neurons and glial cells that repre-
sent only a small fraction of cells in the whole hypothala-
mus. Such a small population of cells would be difficult 
to detect by PCR analysis of the whole medial basal hy-
pothalamus. It is also possible that the alterations in gene 
expression observed in HH-1 are gender-dependent, and 
that, because of this, are not readily detectable in female 
monkeys undergoing normal puberty. Further studies 
are necessary not only to resolve these issues, but also to 
determine if expression in an in vitro context of key genes 
overexpressed in HH-1 results in the production of GnRH 
secretagogues able to accelerate the onset of puberty.
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